Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Wegovy: Prescribed specifically for chronic weight management in adults with obesity or those overweight with at least one weight-related condition (high blood pressure or high cholesterol)
Physiological Reviews, 87 (4), 14091439
Post-marketing surveillance data have not identified infertility as a recognized adverse effect, though such passive reporting systems have inherent limitations in detecting subtle reproductive impacts
Patients should contact their healthcare provider before starting semaglutide if they are taking anticoagulants, even if the prescribing physician is aware of their medication list
Warning: Risk of Thyroid C-Cell Tumors In studies with mice and rats, semaglutide (the active ingredient in Wegovy and Ozempic) caused thyroid tumors, including thyroid cancer
Most other countries, including Australia and Poland, have only approved tirzepatide under the name Mounjaro, Eli Lillys original brand approved by the U.S
